Search

Your search keyword '"Scheinost, Sebastian"' showing total 22 results

Search Constraints

Start Over You searched for: Author "Scheinost, Sebastian" Remove constraint Author: "Scheinost, Sebastian"
22 results on '"Scheinost, Sebastian"'

Search Results

1. Proteogenomics refines the molecular classification of chronic lymphocytic leukemia

2. Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia

3. Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53

5. Table S3 from MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma

6. Table S2, Table S4, Table S6, Figure S1, Figure S2, Figure S3, Figure S4, Figure S5, Figure S6, Supplementary Methods from MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma

7. Data from MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma

8. Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL

9. Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL

10. Proteogenomics refines the molecular classification of chronic lymphocytic leukemia

11. The protein landscape of chronic lymphocytic leukemia

13. Combinatorial drug-microenvironment interaction mapping reveals cell-extrinsic drug resistance mechanisms and clinically relevant patient subgroups in CLL

14. Proteogenomic Subtyping of Chronic Lymphocytic Leukemia Identifies a Novel Poor Outcome Subgroup with a Distinct Drug Response Profile

15. SAMHD1 mutations in mantle cell lymphoma are recurrent and confer in vitro resistance to nucleoside analogues

16. Systematic Investigation of Microenvironmental Drug Resistance Mechanisms in Chronic Lymphocytic Leukemia

17. MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma

18. MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma

19. Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique (GFCH) and the French Innovative Leukemia Organization (FILO) Group

20. Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYCand TP53

21. Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYCand TP53Abnormalities. on Behalf of the Groupe Francophone De Cytogenetique Hematologique(GFCH) and the French Innovative Leukemia Organization(FILO) Group

22. Lymphoma and Leukemia Cell Vulnerabilities and Resistance Identified by Compound Library Screens.

Catalog

Books, media, physical & digital resources